questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Facteurs de transcription
Facteurs de transcription GATA
Facteur de transcription GATA-6
Facteur de transcription GATA-6 : Questions médicales fréquentes
Diagnostic
5
Génétique
Analyse d'expression génique
Marqueurs biologiques
ARNm
Généticiens
Endocrinologie
Maladies cardiaques
Troubles du développement
Symptômes
5
Malformations congénitales
Troubles respiratoires
Développement embryonnaire
Facteurs de transcription
Anomalies cardiaques
Problèmes de croissance
Troubles neurologiques
Facteurs de transcription
Métabolisme
Régulation cellulaire
Prévention
5
Surveillance prénatale
Conseils génétiques
Facteurs environnementaux
Toxines
Alimentation
Développement embryonnaire
Traitements
5
Traitements
Facteurs de transcription
Thérapie génique
Expression génique
Médicaments
Voies de signalisation
Interventions chirurgicales
Malformations
Thérapies complémentaires
Gestion des symptômes
Complications
5
Complications
Malformations cardiaques
Cancer
Facteurs de transcription
Complications neurologiques
Anomalies
Gestion des complications
Approche multidisciplinaire
Facteurs de risque
5
Facteurs de risque
Antécédents familiaux
Maladies maternelles
Diabète
Consommation de substances
Grossesse
Infections maternelles
Développement
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Facteur de transcription GATA-6 : Questions médicales les plus fréquentes",
"headline": "Facteur de transcription GATA-6 : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Facteur de transcription GATA-6 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-17",
"dateModified": "2026-08-05",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Facteur de transcription GATA-6"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Facteurs de transcription GATA",
"url": "https://questionsmedicales.fr/mesh/D050980",
"about": {
"@type": "MedicalCondition",
"name": "Facteurs de transcription GATA",
"code": {
"@type": "MedicalCode",
"code": "D050980",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.930.314"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Facteur de transcription GATA-6",
"alternateName": "GATA6 Transcription Factor",
"code": {
"@type": "MedicalCode",
"code": "D050993",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Paul Kubes",
"url": "https://questionsmedicales.fr/author/Paul%20Kubes",
"affiliation": {
"@type": "Organization",
"name": "Department of Physiology and Pharmacology, University of Calgary, 3330 Hospital Drive NW, Calgary, AB, T2N 4N1, Canada. pkubes@ucalgary.ca."
}
},
{
"@type": "Person",
"name": "Bo Yan",
"url": "https://questionsmedicales.fr/author/Bo%20Yan",
"affiliation": {
"@type": "Organization",
"name": "Shandong Provincial Key Laboratory of Cardiac Disease Diagnosis and Treatment, Affiliated Hospital of Jining Medical University, Jining 272029, China."
}
},
{
"@type": "Person",
"name": "Raymond Shim",
"url": "https://questionsmedicales.fr/author/Raymond%20Shim",
"affiliation": {
"@type": "Organization",
"name": "Department of Physiology and Pharmacology, University of Calgary, 3330 Hospital Drive NW, Calgary, AB, T2N 4N1, Canada."
}
},
{
"@type": "Person",
"name": "Woo-Yong Lee",
"url": "https://questionsmedicales.fr/author/Woo-Yong%20Lee",
"affiliation": {
"@type": "Organization",
"name": "Snyder Institute for Chronic Diseases, University of Calgary, 3330 Hospital Drive NW, Calgary, AB, T2N 4N1, Canada."
}
},
{
"@type": "Person",
"name": "Lu Chen",
"url": "https://questionsmedicales.fr/author/Lu%20Chen",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Reproductive Medicine, Department of Pathogen Biology and Immunology, Jiangsu Province Key Laboratory of Modern Pathogen Biology, Nanjing Medical University, Nanjing, Jiangsu, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "GATA6 inhibits the biological function of non-small cell lung cancer by modulating glucose metabolism.",
"datePublished": "2024-03-14",
"url": "https://questionsmedicales.fr/article/38483616",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00432-024-05664-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Combination immunohistochemistry for CK5/6, p63, GATA6, and HNF4a predicts clinical outcome in treatment-naïve pancreatic ductal adenocarcinoma.",
"datePublished": "2024-07-06",
"url": "https://questionsmedicales.fr/article/38971768",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-65900-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "GATA6-AS1 suppresses epithelial-mesenchymal transition of pancreatic cancer under hypoxia through regulating SNAI1 mRNA stability.",
"datePublished": "2023-12-06",
"url": "https://questionsmedicales.fr/article/38057853",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12967-023-04757-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comprehensive Analysis and Characterization of the GATA Gene Family, with Emphasis on the GATA6 Transcription Factor in Poplar.",
"datePublished": "2023-09-14",
"url": "https://questionsmedicales.fr/article/37762421",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms241814118"
}
},
{
"@type": "ScholarlyArticle",
"name": "Dysregulated expression of GATA2 and GATA6 transcription factors in adenomyosis: implications for impaired endometrial receptivity.",
"datePublished": "2023-11-14",
"url": "https://questionsmedicales.fr/article/37972693",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.xfss.2023.11.003"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Facteurs de transcription",
"item": "https://questionsmedicales.fr/mesh/D014157"
},
{
"@type": "ListItem",
"position": 5,
"name": "Facteurs de transcription GATA",
"item": "https://questionsmedicales.fr/mesh/D050980"
},
{
"@type": "ListItem",
"position": 6,
"name": "Facteur de transcription GATA-6",
"item": "https://questionsmedicales.fr/mesh/D050993"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Facteur de transcription GATA-6 - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Facteur de transcription GATA-6",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-09-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Facteur de transcription GATA-6",
"description": "Comment diagnostiquer une anomalie de GATA-6 ?\nQuels tests sont utilisés pour GATA-6 ?\nY a-t-il des marqueurs associés à GATA-6 ?\nQuels spécialistes évaluent GATA-6 ?\nGATA-6 est-il lié à des maladies spécifiques ?",
"url": "https://questionsmedicales.fr/mesh/D050993#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Facteur de transcription GATA-6",
"description": "Quels symptômes sont liés à GATA-6 ?\nGATA-6 affecte-t-il le développement embryonnaire ?\nY a-t-il des signes cliniques de dysfonction de GATA-6 ?\nLes troubles neurologiques sont-ils liés à GATA-6 ?\nGATA-6 influence-t-il le métabolisme ?",
"url": "https://questionsmedicales.fr/mesh/D050993#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Facteur de transcription GATA-6",
"description": "Peut-on prévenir les anomalies liées à GATA-6 ?\nY a-t-il des facteurs environnementaux à éviter ?\nL'alimentation influence-t-elle GATA-6 ?\nLes vaccinations sont-elles importantes ?\nLe suivi médical est-il crucial ?",
"url": "https://questionsmedicales.fr/mesh/D050993#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Facteur de transcription GATA-6",
"description": "Quels traitements ciblent GATA-6 ?\nPeut-on modifier l'expression de GATA-6 ?\nY a-t-il des médicaments associés à GATA-6 ?\nLes interventions chirurgicales sont-elles nécessaires ?\nDes thérapies complémentaires sont-elles efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D050993#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Facteur de transcription GATA-6",
"description": "Quelles complications peuvent survenir avec GATA-6 ?\nGATA-6 est-il lié à des risques de cancer ?\nY a-t-il des complications neurologiques ?\nLes complications sont-elles réversibles ?\nComment gérer les complications liées à GATA-6 ?",
"url": "https://questionsmedicales.fr/mesh/D050993#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Facteur de transcription GATA-6",
"description": "Quels sont les facteurs de risque pour GATA-6 ?\nL'âge maternel influence-t-il GATA-6 ?\nLes maladies maternelles affectent-elles GATA-6 ?\nY a-t-il des risques liés à la consommation de substances ?\nLes infections maternelles sont-elles un risque ?",
"url": "https://questionsmedicales.fr/mesh/D050993#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie de GATA-6 ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses d'expression génique peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour GATA-6 ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent la PCR et le séquençage de l'ADN pour détecter des mutations."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs associés à GATA-6 ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des marqueurs comme l'ARNm de GATA-6 peuvent indiquer son expression."
}
},
{
"@type": "Question",
"name": "Quels spécialistes évaluent GATA-6 ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les généticiens et les endocrinologues sont souvent impliqués dans l'évaluation."
}
},
{
"@type": "Question",
"name": "GATA-6 est-il lié à des maladies spécifiques ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est associé à des maladies cardiaques et des troubles du développement."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à GATA-6 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des malformations congénitales et des troubles respiratoires."
}
},
{
"@type": "Question",
"name": "GATA-6 affecte-t-il le développement embryonnaire ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il joue un rôle crucial dans le développement embryonnaire normal."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cliniques de dysfonction de GATA-6 ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies cardiaques et des problèmes de croissance peuvent être observés."
}
},
{
"@type": "Question",
"name": "Les troubles neurologiques sont-ils liés à GATA-6 ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien entre GATA-6 et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "GATA-6 influence-t-il le métabolisme ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est impliqué dans la régulation du métabolisme cellulaire."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les anomalies liées à GATA-6 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surveillance prénatale et des conseils génétiques peuvent aider à la prévention."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux à éviter ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les toxines et les médicaments nocifs pendant la grossesse peut réduire les risques."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle GATA-6 ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut soutenir le développement embryonnaire sain."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations appropriées peuvent prévenir certaines infections pendant la grossesse."
}
},
{
"@type": "Question",
"name": "Le suivi médical est-il crucial ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi médical régulier est essentiel pour détecter des anomalies précocement."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent GATA-6 ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de traitements spécifiques ciblant GATA-6."
}
},
{
"@type": "Question",
"name": "Peut-on modifier l'expression de GATA-6 ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des approches de thérapie génique pourraient potentiellement moduler son expression."
}
},
{
"@type": "Question",
"name": "Y a-t-il des médicaments associés à GATA-6 ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments peuvent influencer les voies de signalisation liées à GATA-6."
}
},
{
"@type": "Question",
"name": "Les interventions chirurgicales sont-elles nécessaires ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des interventions peuvent être nécessaires pour corriger des malformations associées."
}
},
{
"@type": "Question",
"name": "Des thérapies complémentaires sont-elles efficaces ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies complémentaires peuvent aider à gérer les symptômes, mais pas GATA-6 directement."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec GATA-6 ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des malformations cardiaques et des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "GATA-6 est-il lié à des risques de cancer ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien entre GATA-6 et le développement de cancers."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications neurologiques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles neurologiques peuvent survenir en raison d'anomalies de GATA-6."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées à GATA-6 ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une approche multidisciplinaire est souvent nécessaire pour gérer les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour GATA-6 ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux et certaines expositions environnementales sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'âge maternel influence-t-il GATA-6 ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un âge maternel avancé peut augmenter le risque d'anomalies liées à GATA-6."
}
},
{
"@type": "Question",
"name": "Les maladies maternelles affectent-elles GATA-6 ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies comme le diabète peuvent influencer le développement de GATA-6."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques liés à la consommation de substances ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "La consommation d'alcool et de drogues pendant la grossesse augmente les risques."
}
},
{
"@type": "Question",
"name": "Les infections maternelles sont-elles un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections pendant la grossesse peuvent affecter GATA-6 et le développement."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 05/08/2026
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Physiology and Pharmacology, University of Calgary, 3330 Hospital Drive NW, Calgary, AB, T2N 4N1, Canada. pkubes@ucalgary.ca.
Snyder Institute for Chronic Diseases, University of Calgary, 3330 Hospital Drive NW, Calgary, AB, T2N 4N1, Canada. pkubes@ucalgary.ca.
Department of Microbiology and Immunology, University of Calgary, 3330 Hospital Drive NW, Calgary, AB, T2N 4N1, Canada. pkubes@ucalgary.ca.
Publications dans "Facteur de transcription GATA-6" :
2 publications dans cette catégorie
Affiliations :
Shandong Provincial Key Laboratory of Cardiac Disease Diagnosis and Treatment, Affiliated Hospital of Jining Medical University, Jining 272029, China.
The Center for Molecular Genetics of Cardiovascular Diseases, Affiliated Hospital of Jining Medical University, Jining 272029, China.
Shandong Provincial Sino-US Cooperation Research Center for Translational Medicine, Affiliated Hospital of Jining Medical University, Jining 272029, China.
Publications dans "Facteur de transcription GATA-6" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology and Pharmacology, University of Calgary, 3330 Hospital Drive NW, Calgary, AB, T2N 4N1, Canada.
Snyder Institute for Chronic Diseases, University of Calgary, 3330 Hospital Drive NW, Calgary, AB, T2N 4N1, Canada.
Publications dans "Facteur de transcription GATA-6" :
2 publications dans cette catégorie
Affiliations :
Snyder Institute for Chronic Diseases, University of Calgary, 3330 Hospital Drive NW, Calgary, AB, T2N 4N1, Canada.
Publications dans "Facteur de transcription GATA-6" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Reproductive Medicine, Department of Pathogen Biology and Immunology, Jiangsu Province Key Laboratory of Modern Pathogen Biology, Nanjing Medical University, Nanjing, Jiangsu, China.
Publications dans "Facteur de transcription GATA-6" :
2 publications dans cette catégorie
Affiliations :
Department of Biological Repositories, Frontier Science Center for Immunology and Metabolism, Medical Research Institute, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430071, China.
Publications dans "Facteur de transcription GATA-6" :
2 publications dans cette catégorie
Affiliations :
From the Yale Cardiovascular Research Center (R.S., H.R., Y.X., N.L., N,B., L.H., F.E., J.Z., G.G., K.A.M., A.M.), Yale School of Medicine, New Haven, CT.
Publications dans "Facteur de transcription GATA-6" :
2 publications dans cette catégorie
Affiliations :
Department of Metabolism and Endocrinology, The Third Hospital of Changsha, Laodongxi Road #176, Changsha, 410011, Hunan, People's Republic of China.
Publications dans "Facteur de transcription GATA-6" :
2 publications dans cette catégorie
Affiliations :
Department of Oncology, Liaocheng People's Hospital, 67 Dongchang West Road, Liaocheng, 252000, Shandong, China. zj2684@hotmail.com.
Publications dans "Facteur de transcription GATA-6" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Medical Neurobiology, MOE Frontier Research Center for Brain Science, Department of Neurology, Institutes of Brain Science, Zhongshan Hospital, Fudan University, Shanghai, China.
Publications dans "Facteur de transcription GATA-6" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Medical Neurobiology, MOE Frontier Research Center for Brain Science, Department of Neurology, Institutes of Brain Science, Zhongshan Hospital, Fudan University, Shanghai, China.
Publications dans "Facteur de transcription GATA-6" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Tree Genetics and Breeding, Northeast Forestry University, Harbin 150040, China.
Publications dans "Facteur de transcription GATA-6" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Plant Biotechnology of Liaoning Province, School of Life Sciences, Liaoning Normal University, Dalian 116081, China.
Publications dans "Facteur de transcription GATA-6" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Plant Biotechnology of Liaoning Province, School of Life Sciences, Liaoning Normal University, Dalian 116081, China.
Publications dans "Facteur de transcription GATA-6" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Plant Biotechnology of Liaoning Province, School of Life Sciences, Liaoning Normal University, Dalian 116081, China.
Publications dans "Facteur de transcription GATA-6" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Plant Biotechnology of Liaoning Province, School of Life Sciences, Liaoning Normal University, Dalian 116081, China.
Publications dans "Facteur de transcription GATA-6" :
2 publications dans cette catégorie
Affiliations :
Sanya Nanfan Research Institute, Hainan University, Sanya 572025, China.
School of Tropical Agriculture and Forestry, Hainan University, Haikou 570228, China.
Publications dans "Facteur de transcription GATA-6" :
2 publications dans cette catégorie
Affiliations :
Sanya Nanfan Research Institute, Hainan University, Sanya 572025, China.
School of Tropical Agriculture and Forestry, Hainan University, Haikou 570228, China.
Publications dans "Facteur de transcription GATA-6" :
2 publications dans cette catégorie
Affiliations :
Sanya Nanfan Research Institute, Hainan University, Sanya 572025, China.
Publications dans "Facteur de transcription GATA-6" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Entomology and Pest Control Engineering, College of Plant Protection, Southwest University, Chongqing, China.
State Cultivation Base of Crop Stress Biology for Southern Mountainous Land, Southwest University, Chongqing, China.
International Joint Laboratory of China-Belgium on Sustainable Crop Pest Control, Academy of Agricultural Sciences, Southwest University, Chongqing, China.
Publications dans "Facteur de transcription GATA-6" :
This study aims to explore the role of GATA6 in lung cancer, with a focus on its impact on metabolic processes....
We assessed GATA6 expression in lung cancer tissues and its association with patient prognosis. In vitro cell function experiments were conducted to investigate the effects of altered GATA6 levels on ...
Our study revealed significant down-regulation of GATA6 in lung cancer tissues, and this down-regulation was strongly correlated with unfavorable patient prognosis. Elevating GATA6 levels effectively ...
Our study provides crucial insights into the metabolic regulation of GATA6 in lung cancer cells. These findings have the potential to offer a solid theoretical foundation for the development of novel ...
Although sequence-based studies show that basal-like features lead to worse prognosis and chemotherapy-resistance compared to the classical subtype in advanced pancreatic ductal adenocarcinoma (PDAC),...
Pancreatic ductal adenocarcinoma (PDAC) is characterized by a hypoxic microenvironment, a high rate of heterogeneity as well as a high likelihood of recurrence. Mounting evidence has affirmed that lon...
GATA transcription factors are ubiquitously present in eukaryotic organisms and play a crucial role in multiple biological processes, such as plant growth, stress response, and hormone signaling. Howe...
To study the effect of adenomyosis on the localized expression of the GATA binding proteins 2 and 6 (GATA2 and GATA6) zinc-finger transcription factors that are involved in proliferation of hematopoie...
Laboratory based experimental study....
Academic hospital and laboratory....
Human endometrial stromal cells (HESCs) of reproductive age patients, 18-45 years of age, with adenomyosis were compared with patients with no pathology and leiomyomatous uteri as controls (n = 4 in e...
GATA2 and GATA6 immunohistochemistry and H-SCORE were performed on the midsecretory phase endometrial sections from adenomyosis and leiomyoma control patients (n = 8 each, respectively). Control and a...
Immunohistochemistry was performed to obtain GATA2 and GATA6 H-SCORES in adenomyosis vs. control patient endometrial tissue. Expression of GATA2, GATA6, insulin-like growth factor-binding protein 1 (I...
Immunohistochemistry revealed an overall fourfold lower GATA2 and fourfold higher GATA6 H-SCORE level in the endometrial stromal cells of patients with adenomyosis vs. controls. Decidual induction wit...
In-vivo and in-vitro experiment results demonstrate that there is an overall inverse relationship between endometrial GATA2 and GATA6 levels in patients with adenomyosis who have diminished GATA2 leve...
Lung squamous cell carcinoma (LUSC) is associated with high mortality and has limited therapeutic treatment options. Plasminogen activator urokinase (PLAU) plays important roles in tumor cell malignan...
To identify the potential target genes regulated by GATA6, differentially expressed genes (DEGs) obtained from GEO datasets analysis and RNA-seq experiment were subjected to Venn analysis and correlat...
PLAU overexpression promoted LUSC cell proliferation and migration. PLAU is overexpressed in LUSC tissues compared with normal tissues. Consistently, high PLAU expression, which acts as an independent...
In this work, it was revealed that PLAU is a novel oncogene for LUSC and a new molecular regulatory mechanism of GATA6 in LUSC was unveiled. Targeting the GATA6/PLAU pathway might help in the developm...
Prior research has suggested that GATA6...
Arterial calcification is a hallmark of vascular pathology in the elderly and in individuals with chronic kidney disease (CKD). Vascular smooth muscle cells (VSMCs), after attaining a senescent phenot...
Dedifferentiation is the process by which terminally differentiated cells acquire the properties of stem cells. During mouse skin wound healing, the differentiated Gata6-lineage positive cells of the ...
As global climate change continues, drought episodes have become increasingly frequent. Studying plant stress tolerance is urgently needed to ensure food security. The common ice plant is one of the m...